Mercer: Next eight years will see disruptions in care delivery, particularly in personalized medicine

In this white paper, Mercer explains that healthcare delivery was stable the past four decades, the next eight years are poised for disruptions as rising costs and government cutbacks continue. One innovation is personalized medicine, which Mercer contends will mitigate some of the inflationary pressures from specialty drugs. It adds that pharmacogenetics - using a patient's genes to determine the best course of therapy - will bring some cost certainty to drug plans as less time and money is spent experimenting with treatments.